Literature DB >> 20608971

BRCA1 16 years later: DNA damage-induced BRCA1 shuttling.

Eddy S Yang1, Fen Xia.   

Abstract

The tumor suppressor, breast cancer susceptibility gene 1 (BRCA1), plays an integral role in the maintenance of genome stability and, in particular, the cellular response to DNA damage. Here, the emerging role of BRCA1 in nonhomologous end-joining-mediated DNA repair following DNA damage will be reviewed, as well as the activation of apoptotic pathways. The control of these functions via DNA damage-induced BRCA1 shuttling will also be discussed, in particular BRCA1 shuttling induced by erlotinib and irradiation. Finally, the potential targeting of BRCA1 shuttling as a novel strategy to sensitize cells to DNA damage will be entertained.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608971      PMCID: PMC6158790          DOI: 10.1111/j.1742-4658.2010.07734.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  62 in total

1.  BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene.

Authors:  J N Snouwaert; L C Gowen; A M Latour; A R Mohn; A Xiao; L DiBiase; B H Koller
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

2.  Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.

Authors:  Klaus Dittmann; Claus Mayer; Birgit Fehrenbacher; Martin Schaller; Uma Raju; Luka Milas; David J Chen; Rainer Kehlbach; H Peter Rodemann
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

3.  Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

Authors:  Prakash Chinnaiyan; Shyhmin Huang; Geetha Vallabhaneni; Eric Armstrong; Sooryanarayana Varambally; Scott A Tomlins; Arul M Chinnaiyan; Paul M Harari
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

4.  BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.

Authors:  Megan Fabbro; Jose A Rodriguez; Richard Baer; Beric R Henderson
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

Review 5.  The epidermal growth factor receptor pathway: a model for targeted therapy.

Authors:  Maurizio Scaltriti; José Baselga
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

Review 6.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

7.  The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor.

Authors:  C F Chen; S Li; Y Chen; P L Chen; Z D Sharp; W H Lee
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

8.  Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.

Authors:  Anna W Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galina Chipitsyna; Kartik Aysola; Vaishali Reddy; Ganapathy Bhat; Yasuo Fujimura; Beric Henderson; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

9.  Caspase-dependent BRCA1 cleavage facilitates chemotherapy-induced apoptosis.

Authors:  Eva Dizin; Hind Ray; Florent Suau; Thibault Voeltzel; Nicole Dalla Venezia
Journal:  Apoptosis       Date:  2008-02       Impact factor: 4.677

10.  Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends.

Authors:  Josée Guirouilh-Barbat; Emilie Rass; Isabelle Plo; Pascale Bertrand; Bernard S Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

View more
  18 in total

Review 1.  The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.

Authors:  Yaqin Tu; Cai Chen; Junru Pan; Junfa Xu; Zhi-Guang Zhou; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

Review 2.  Functional analyses of human DNA repair proteins important for aging and genomic stability using yeast genetics.

Authors:  Monika Aggarwal; Robert M Brosh
Journal:  DNA Repair (Amst)       Date:  2012-02-18

3.  Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent.

Authors:  Steven T Sizemore; Rahman Mohammad; Gina M Sizemore; Somaira Nowsheen; Hao Yu; Michael C Ostrowski; Arnab Chakravarti; Fen Xia
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

4.  The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination.

Authors:  Mohammad Abbas; Ilanchezhian Shanmugam; Manal Bsaili; Robert Hromas; Monte Shaheen
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

5.  Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma.

Authors:  Tong Wang; Sabrina C Wentz; Natalie L Ausborn; M Kay Washington; Nipun Merchant; Zhiguo Zhao; Yu Shyr; A Bapsi Chakravarthy; Fen Xia
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

Review 6.  The intersection between DNA damage response and cell death pathways.

Authors:  S Nowsheen; E S Yang
Journal:  Exp Oncol       Date:  2012-10

7.  Identification and frequency of the rs12516 and rs8176318 BRCA1 gene polymorphisms among different populations.

Authors:  Fang Yang; Fengxia Chen; Jin Xu; Xiaoxiang Guan
Journal:  Oncol Lett       Date:  2016-02-19       Impact factor: 2.967

8.  BRCA1-Dependent Translational Regulation in Breast Cancer Cells.

Authors:  Estelle Dacheux; Anne Vincent; Nicolas Nazaret; Christophe Combet; Anne Wierinckx; Sylvie Mazoyer; Jean-Jacques Diaz; Joël Lachuer; Nicole Dalla Venezia
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

9.  Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.

Authors:  Somaira Nowsheen; Tiffiny Cooper; Jennifer A Stanley; Eddy S Yang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer.

Authors:  Kenneth J O'Byrne; Martin P Barr; Steven G Gray
Journal:  Cancers (Basel)       Date:  2011-03-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.